Aemetis (AMTX)
Coverage summary
Aardvark Labs Capital Research has covered Aemetis (AMTX) since August 8, 2025. The company is in the Basic Materials sector. This page lists 6 reports: 6 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published November 6, 2026. The current rating is Hold, unchanged since the Q1 2026 Earnings Recap of May 8, 2026. The rating has changed twice since coverage began.
Translations: 5 in Chinese.
Rating history
All AMTX reports
Recap: Q3 2026
Aemetis’s dairy credit reset brings interest coverage closer
Recap: Q2 2026
Aemetis Q2: Operating Income Turns Positive for the First Time Since 2021, and Still Does Not Cover the Interest
Recap: Q1 2026
Aemetis Q1: The Thesis Keeps Printing, but a Going-Concern Flag Resets the Risk/Reward
Recap: Q4 2025
Aemetis Q4: The Catalysts Finally Print, and the Thesis Inflects
Recap: Q3 2025
Aemetis Q3: The Business Inches Toward Breakeven, the Catalysts Slip Again
Recap: Q2 2025
Aemetis Q2: A Real Catalyst Stack Behind a DOE Delay, Built on $1.6M of Cash